Report: 650% Spike In Cannabis Medicine Trials Prioritizing Chronic And Neuropathic Pain

 Report: 650% Spike In Cannabis Medicine Trials Prioritizing Chronic And Neuropathic Pain

Could the future of healthcare be intertwined with cannabis-based medicines?A recent report by Prohibition Partners, a data, media and tech company operating in the cannabis industry, reveals a remar…